 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > LifeCell Corporation
 |
LifeCell Corporation |
 |
 |
 |
PROFILE |
 |
LifeCell puts new life into the tissue graft market. The company makes skin graft materials processed from cadaver skin. Its products include AlloDerm, used in reconstructive plastic, dental, and burn surgeries; Cymetra, marketed to dermatologists and plastic surgeons; and Repliform, used in urologic and gynecological procedures. These products are sold in the US and select foreign countries through such distributors as Boston Scientific (about 30% of LifeCell's sales) and Obagi Medical Products (about 15%). The company is developing other biomedical products, including vascular grafts and ThromboSol, a storage solution designed to extend the shelf life of blood used in transfusions.
COMPETITION |
 |
Advanced Tissue Sciences, Inc. (ATIS)
Genzyme Corporation (GENZ)
Organogenesis Inc. (ORG)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 22.80
1-Yr. Sales Growth: 79.5%
Employees: 157
Revenue per employee: $145,222.93
KEY PEOPLE |
 |
Paul G. Thomas
CEO
CONTACT INFO |
 |
1 Millennium Way
Branchburg, NJ 08876
US
Phone: 908-947-1100
Fax: 908-947-1200
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |